Reduction in Cell Viability and in Homeobox Protein Levels Following in Vitro Exposure to δ-tocopherol in Acute Myeloid Leukemia

References

• Guan F, Li G, Liu AB, Lee MJ, Yang Z, et al.: delta- and gamma-tocopherols, but not alpha-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats. Cancer Prev Res (Phila) 5, 644–654, 2012. doi: 10.1158/1940-6207.capr-11-0521
   PubMed Web of Science ®Google Scholar
• Smolarek AK and Suh N: Chemopreventive activity of vitamin E in breast cancer: a focus on gamma- and delta-tocopherol. Nutrients 3, 962–986, 2011. doi: 10.3390/nu3110962
   PubMed Web of Science ®Google Scholar
• Campbell SE, Musich PR, Whaley SG, Stimmel JB, Leesnitzer LM, et al.: Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells. Nutr Cancer 61, 649–662, 2009. doi: 10.1080/01635580902825654
   PubMed Web of Science ®Google Scholar
• Campbell SE, Stone WL, Whaley SG, Qui M and Krishnan K: Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer 3, 25, 2003. doi: 10.1186/1471-2407-3-25
   PubMed Web of Science ®Google Scholar
• Ahsan H, Ahad A, Iqbal J and Siddiqui WA: Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond) 11, 52, 2014. doi: 10.1186/1743-7075-11-52
   PubMed Web of Science ®Google Scholar
• Reiter E, Jiang Q and Christen S: Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol Aspects Med 28, 668–691, 2007. doi: 10.1016/j.mam.2007.01.003
   PubMed Web of Science ®Google Scholar
• Virtamo J, Taylor PR, Kontto J, Mannisto S, Utriainen M, et al.: Effects of alpha-tocopherol and beta-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer 135, 178–185, 2014. doi: 10.1002/ijc.28641
   PubMed Web of Science ®Google Scholar
• Li GX, Lee MJ, Liu AB, Yang Z, Lin Y, et al.: delta-tocopherol is more active than alpha - or gamma -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prev Res (Phila) 4, 404–413, 2011. doi: 10.1158/1940-6207.capr-10-0130
   PubMed Web of Science ®Google Scholar
• Yu W, Simmons-Menchaca M, Gapor A, Sanders BG and Kline K: Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 33, 26–32, 1999. doi: 10.1080/01635589909514744
   PubMed Web of Science ®Google Scholar
• McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, et al.: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35, 171–180, 2000
   PubMed Web of Science ®Google Scholar
• Huang H, He Y, Cui XX, Goodin S, Wang H, et al.: Potent inhibitory effect of delta-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivo. J Agric Food Chem 62, 10752–10758, 2014. doi: 10.1021/jf504058f
   PubMed Web of Science ®Google Scholar
• Baxter LL, Marugan JJ, Xiao J, Incao A, McKew JC, et al.: Plasma and tissue concentrations of alpha-tocopherol and delta-tocopherol following high dose dietary supplementation in mice. Nutrients 4, 467–490, 2012. doi: 10.3390/nu4060467
   PubMed Web of Science ®Google Scholar
• Inoue A, Takitani K, Koh M, Kawakami C, Kuno T, et al.: Induction of apoptosis by gamma-tocotrienol in human cancer cell lines and leukemic blasts from patients: dependency on Bid, cytochrome c, and caspase pathway. Nutr Cancer 63, 763–770, 2011. doi: 10.1080/01635581.2011.563030
   PubMed Web of Science ®Google Scholar
• Wilankar C, Khan NM, Checker R, Sharma D, Patwardhan R, et al.: gamma-Tocotrienol induces apoptosis in human T cell lymphoma through activation of both intrinsic and extrinsic pathways. Curr Pharm Des 17, 2176–2189, 2011
   PubMed Web of Science ®Google Scholar
• Calviello G, Di Nicuolo F, Piccioni E, Marcocci ME, Serini S, et al.: gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis 24, 427–433, 2003
   PubMed Web of Science ®Google Scholar
• Sharma R and Vinayak M: alpha-Tocopherol prevents lymphoma by improving antioxidant defence system of mice. Mol Biol Rep 40, 839–849, 2013. doi: 10.1007/s11033-012-2123-9
   PubMed Web of Science ®Google Scholar
• Evans HM and Bishop KS: On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56, 650–651, 1922. doi: 10.1126/science.56.1458.650
   PubMedGoogle Scholar
• Richardson ME, Bleiziffer A, Tuttelmann F, Gromoll J and Wilkinson MF: Epigenetic regulation of the RHOX homeobox gene cluster and its association with human male infertility. Hum Mol Genet 23, 12–23, 2014. doi: 10.1093/hmg/ddt392
   PubMed Web of Science ®Google Scholar
• Benson GV, Lim H, Paria BC, Satokata I, Dey SK, et al.: Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122, 2687–2696, 1996
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez J: The genesis and evolution of homeobox gene clusters. Nat Rev Genet 6, 881–892, 2005. doi: 10.1038/nrg1723
   PubMed Web of Science ®Google Scholar
• Rice KL and Licht JD: HOX deregulation in acute myeloid leukemia. J Clin Invest 117, 865–868, 2007. doi: 10.1172/jci31861
   PubMed Web of Science ®Google Scholar
• Nesaretnam K, Stephen R, Dils R and Darbre P: Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33, 461–469, 1998
   PubMed Web of Science ®Google Scholar
• Collins CT and Hess JL: Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene 2015. doi: 10.1038/onc.2015.174
   Web of Science ®Google Scholar
• Li DP, Li ZY, Sang W, Cheng H, Pan XY, et al.: HOXA9 gene expression in acute myeloid leukemia. Cell Biochem Biophys 67, 935–938, 2013. doi: 10.1007/s12013-013-9586-8
   PubMed Web of Science ®Google Scholar
• Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, et al.: Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17, 3714–3725, 1998. doi: 10.1093/emboj/17.13.3714
   PubMed Web of Science ®Google Scholar
• Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, et al.: Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13, 1993–1999, 1999
   PubMed Web of Science ®Google Scholar
• Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, et al.: Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells. Oncogene 28, 4364–4374, 2009. doi: http://www.nature.com/onc/journal/v28/n49/suppinfo/onc2009288s1.html
   PubMed Web of Science ®Google Scholar
• Dardaei L, Longobardi E and Blasi F: Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A 111, E896–E905, 2014. doi: 10.1073/pnas.1321200111
   Google Scholar
• Faber K, Bullinger L, Ragu C, Garding A, Mertens D, et al.: CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARgamma signaling. J Clin Invest 123, 299–314, 2013. doi: 10.1172/jci64745
   PubMed Web of Science ®Google Scholar
• Scholl C, Bansal D, Dohner K, Eiwen K, Huntly BJ, et al.: The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest 117, 1037–1048, 2007. doi: 10.1172/jci30182
   PubMed Web of Science ®Google Scholar
• Ossenkoppele G and Lowenberg B: How I treat the older patient with acute myeloid leukemia. Blood 125, 767–774, 2015. doi: 10.1182/blood-2014-08-551499
   PubMed Web of Science ®Google Scholar
• Radosevic N, Delmer A, Tang R and Marie JP: Ajchenbaum-Cymbalista F: Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. Leukemia 15, 559–566, 2001
   PubMed Web of Science ®Google Scholar
• Wang YX, Zhang JH and Gu ZW: [Beta-catenin and cyclin D1 mRNA levels in newly diagnosed patients with acute myeloid leukemia and their significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17, 304–308, 2009
   PubMedGoogle Scholar
• Jaroslav P, Martina H, Jiri S, Hana K, Petr S, et al.: Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia. Leuk Lymphoma 46, 1605–1612, 2005
   PubMed Web of Science ®Google Scholar
• Saba N, Wiestner A: Do mantle cell lymphomas have an ‘Achilles heel’? Curr Opin Hematol 21, 350–357, 2014. doi: 10.1097/moh.0000000000000057
   PubMed Web of Science ®Google Scholar